Clinical Trial Update: Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease Patients [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and tolerability of ACR325 in patients with Parkinson's disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• ACR325

Snippet

Sponsor: NeuroSearch A/S | Conditions: Parkinson's Disease, Tolerability | Phase 1 | Status: COMPLETED